Search Results - "Smit, Leonie"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Risk of regional recurrence in triple-negative breast cancer patients: a Dutch cohort study by van Roozendaal, Lori M., Smit, Leonie H. M., Duijsens, Gaston H. N. M., de Vries, Bart, Siesling, Sabine, Lobbes, Marc B. I., de Boer, Maaike, de Wilt, Johannes H. W., Smidt, Marjolein L.

    Published in Breast cancer research and treatment (01-04-2016)
    “…Triple-negative breast cancer is associated with early recurrence and low survival rates. Several trials investigate the safety of a more conservative approach…”
    Get full text
    Journal Article
  2. 2

    The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population by Piek, Arnold, Smit, Leonie, Suthahar, Navin, Bakker, Stephan J. L., de Boer, Rudolf A., Silljé, Herman H. W.

    Published in Scientific reports (21-04-2021)
    “…Dickkopf-3 (DKK3) is an emerging biomarker for cardiovascular disease (CVD) and chronic kidney disease (CKD). Herein, baseline DKK3 plasma levels were measured…”
    Get full text
    Journal Article
  3. 3

    Three-Dimensional Breast Radiotherapy and the Elective Radiation Dose at the Sentinel Lymph Node Site in Breast Cancer by van Roozendaal, Lori M., Schipper, Robert-Jan, Smit, Leonie H. M., Brans, Boudewijn T., Beets-Tan, Regina G. H., Lobbes, Marc B. I., Boersma, Liesbeth J., Smidt, Marjolein L.

    Published in Annals of surgical oncology (01-11-2015)
    “…Background Several trials are presently randomizing clinically node-negative breast cancer patients treated with breast-conserving therapy (BCT) to sentinel…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Serous Tubal Intraepithelial Carcinoma After Neoadjuvant Chemotherapy: A Report of 2 Cases by Stroot, Iris A S, Smit, Leonie, de Bock, Geertruida H, Wagner, Marise M, Jalving, Mathilde, van Kempen, Léon C L T, Bart, Joost, Mourits, Marian J E

    “…Serous tubal intraepithelial carcinoma (STIC) is regarded as the origin of most high-grade serous carcinomas (HGSC). After a diagnosis of isolated STIC, risk…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients by Smit, Léonie H.M., Korse, Catharina M., Hart, Augustinus A.M., Bonfrer, Johannes M.G., Haanen, John B.A.G., Kerst, J. Martijn, Nieweg, Omgo E., de Gast, Gijsbert C.

    Published in European journal of cancer (1990) (01-02-2005)
    “…The value of normal S-100B levels to predict survival was evaluated in 145 patients with stage IV melanoma. Treatment consisted of temozolomide given alone or…”
    Get full text
    Journal Article
  8. 8

    Significance of serum S-100B in melanoma patients before and after sentinel node biopsy by Smit, Léonie H.M., Nieweg, Omgo E., Korse, Catharina M., Bonfrer, Johannes M.G., Kroon, Bin B.R.

    Published in Journal of surgical oncology (01-05-2005)
    “…Background and Objectives The clinical utility of the tumor marker serum S‐100B has been described in determining prognosis, for early diagnosis of recurrence…”
    Get full text
    Journal Article
  9. 9